About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...

Innovative Pharmaceutical Initiative – iF!

The question is not whether we can afford to invest in health. The question is – can we afford not to?

Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia

Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia

The choice before us is clear: the level of investment directly shapes the quality of care, the availability of therapies, and long‑term health outcomes.

In this video, we open up a key question about the future of our healthcare system – how ready are we to invest in health, and what consequences does that decision carry.

Published
27. February 2026.
Source
Category
Tag

Latest News

02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...
01/2026
Interview with Javier Aracil Corma, General Manager of the AbbVie Adriatic and Hungary...
01/2026
Croatia at a crossroads – time for bold decisions in healthcare!...
02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...
Scroll to Top

About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...
Start typing to search